ClinVar Genomic variation as it relates to human health
NM_006129.5(BMP1):c.2134G>A (p.Gly712Ser)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_006129.5(BMP1):c.2134G>A (p.Gly712Ser)
Variation ID: 498501 Accession: VCV000498501.13
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 8p21.3 8: 22201829 (GRCh38) [ NCBI UCSC ] 8: 22059342 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 2, 2018 Nov 24, 2024 Jun 18, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_006129.5:c.2134G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_006120.1:p.Gly712Ser missense NR_033403.2:n.2205G>A non-coding transcript variant NC_000008.11:g.22201829G>A NC_000008.10:g.22059342G>A NG_029659.1:g.41690G>A - Protein change
- G712S
- Other names
-
p.Gly712Ser
- Canonical SPDI
- NC_000008.11:22201828:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
0.00060 (A)
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
1000 Genomes Project 30x 0.00062
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.00062
The Genome Aggregation Database (gnomAD) 0.00064
The Genome Aggregation Database (gnomAD), exomes 0.00080
Exome Aggregation Consortium (ExAC) 0.00094
1000 Genomes Project 0.00060
Trans-Omics for Precision Medicine (TOPMed) 0.00061
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
BMP1 | - | - |
GRCh38 GRCh37 |
723 | 1017 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Uncertain significance (2) |
criteria provided, multiple submitters, no conflicts
|
Feb 22, 2023 | RCV001162110.5 | |
Uncertain significance (4) |
criteria provided, multiple submitters, no conflicts
|
Jun 18, 2024 | RCV000597608.9 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(Dec 13, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000703544.2
First in ClinVar: Apr 02, 2018 Last updated: Apr 02, 2018 |
Number of individuals with the variant: 1
Sex: mixed
|
|
Uncertain significance
(Jun 19, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Osteogenesis imperfecta type 13
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV001324045.1
First in ClinVar: May 31, 2020 Last updated: May 31, 2020 |
Comment:
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, … (more)
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. (less)
|
|
Uncertain significance
(Jul 29, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV002145687.2
First in ClinVar: Mar 28, 2022 Last updated: Feb 07, 2023 |
Comment:
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 712 of the BMP1 protein (p.Gly712Ser). … (more)
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 712 of the BMP1 protein (p.Gly712Ser). This variant is present in population databases (rs117159093, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with BMP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 498501). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. (less)
|
|
Uncertain significance
(May 15, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV003926147.1
First in ClinVar: May 27, 2023 Last updated: May 27, 2023 |
Comment:
Reported in a patient with an atypical femur fracture, however a second BMP1 variant was not identified (Zhou et al., 2023); In silico analysis supports … (more)
Reported in a patient with an atypical femur fracture, however a second BMP1 variant was not identified (Zhou et al., 2023); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 37076969, PollitR2019[thesis]) (less)
|
|
Uncertain significance
(Feb 22, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Osteogenesis imperfecta type 13
Affected status: unknown
Allele origin:
germline
|
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Accession: SCV004562144.1
First in ClinVar: Feb 20, 2024 Last updated: Feb 20, 2024 |
Comment:
The BMP1 c.2134G>A; p.Gly712Ser variant (rs117159093), to our knowledge, is not reported in the medical literature in individuals with osteogenesis imperfecta but is reported in … (more)
The BMP1 c.2134G>A; p.Gly712Ser variant (rs117159093), to our knowledge, is not reported in the medical literature in individuals with osteogenesis imperfecta but is reported in ClinVar (Variation ID: 498501). This variant is found in the non-Finnish European population with an allele frequency of 0.1382% (176/127,382 alleles) in the Genome Aggregation Database. Computational analyses predict that this variant is deleterious (REVEL: 0.858). Due to limited information, the clinical significance of this variant is uncertain at this time. (less)
|
|
Uncertain significance
(Jun 18, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Not provided
Affected status: unknown
Allele origin:
germline
|
Mayo Clinic Laboratories, Mayo Clinic
Accession: SCV005409422.1
First in ClinVar: Nov 24, 2024 Last updated: Nov 24, 2024 |
Comment:
BS1, PP3
Number of individuals with the variant: 1
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Prevalence of Monogenic Bone Disorders in a Dutch Cohort of Atypical Femur Fracture Patients. | Zhou W | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research | 2023 | PMID: 37076969 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=BMP1 | - | - | - | - |
Text-mined citations for rs117159093 ...
HelpRecord last updated Nov 30, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.